We aim to become a valued partner for your product research, development and registration.
WHO WE ARE
Anapharm Bioanalytics is a GLP-certified, FDA-inspected, GCP-compliant and ANVISA-certified bioanalytical contract research organization (CRO) offering comprehensive high quality bioanalytical services to the pharmaceutical, biotechnological and generic industry worldwide.
PHASE I-III & BIOEQUIVALENCE
We provide full service outsourcing solutions to conduct preclinical, Phase I-III clinical trials and bioequivalence studies for registration worldwide. As a leading provider of bioanalytical services we aim to become a valued partner for your product research, development and registration.
We offer 30+ years of experience in analytical method development, validation and sample analysis of both small and large molecules in a variety of biological matrices using state-of-the-art LC-MS/MS and Ligand Binding Assay (LBA) technology platforms.
samples per year
Method development, validation and quantitative sample analysis of small molecules and biologics at any stage of drug development from early preclinical across all phases of clinical development and bioequivalence.
Anapharm Bioanalytics offers an extensive list of validated analytical methods to support bioequivalence, drug-drug interaction and other types of studies. If you are unable to find the assay you need or require the development of a proprietary method, please contact us; we shall be glad to assist you.
Find your method here: